Dear cBioPortal team,
I am a postdoc at the cancer research lab at University Hospital Duesseldorf.
I am using your survival analysis tool to test the impact the expression of 7-gene-group. Trying to dig deeper, we are puzzling how exactly the survival outcome is determine in your pipeline.
We are setting the expression cutoff >=2SD for the group of 7 genes.
Is that cut off based on mean or median?
When we are testing those 7 genes as a group, would it be enough if just one gene's expression is above 2SD to be count in the "altered group", correct?
Is there any code you could provide for us to follow the process? We try to retrace how the results are generated to interpret them better.
May you have there already some contents that you can forward to us?
Thank you for your efforts,
Bianca Behrens
Hi Bianca,
Thank you for reaching out.
We are setting the expression cutoff >=2SD for the group of 7 genes.
Is that cut off based on mean or median?
The cut off is based on the number of standard deviations from the mean.
When we are testing those 7 genes as a group, would it be enough if just one gene's expression is above 2SD to be count in the "altered group", correct?
Yes, the “altered group” is any patient or sample in which at least one of the seven genes in your query has the higher expression.
Is there any code you could provide for us to follow the process? We try to retrace how the results are generated to interpret them better. May you have there already some contents that you can forward to us?
Our Onco Query Language page has some example coding for queries here, including gene expression: https://www.cbioportal.org/oql
We have some slides that walk through the use of OQL as well: https://www.cbioportal.org/tutorials#oql
We also have a video tutorial that looks at expression data. This particular example linked here uses OQL to compare survival rates: https://youtu.be/YUxVv6pkxD4?t=1442
Let us know if you have any further questions,
David M. Higgins, Ph.D. | (he/him)
Scientific Community Program Manager
Center for Data-Driven Discovery in Biomedicine (D3b)
Children’s Hospital of Philadelphia, USA
From: <cbiop...@googlegroups.com> on behalf of "Bianca....@med.uni-duesseldorf.de" <Bianca....@med.uni-duesseldorf.de>
Date: Tuesday, October 19, 2021 at 9:00 AM
To: "cbiop...@googlegroups.com" <cbiop...@googlegroups.com>
Cc: "nikolas.s...@uni-duesseldorf.de" <nikolas.s...@uni-duesseldorf.de>, "Georg....@med.uni-duesseldorf.de" <Georg....@med.uni-duesseldorf.de>, "Rui....@med.uni-duesseldorf.de" <Rui....@med.uni-duesseldorf.de>, "Christop...@med.uni-duesseldorf.de"
<Christop...@med.uni-duesseldorf.de>
Subject: [External][cbioportal] Survival analysis //data processing details
You don't often get email from bianca....@med.uni-duesseldorf.de. Learn why this is important |
--
You received this message because you are subscribed to the Google Groups "cBioPortal for Cancer Genomics Discussion Group" group.
To unsubscribe from this group and stop receiving emails from it, send an email to
cbioportal+...@googlegroups.com.
To view this discussion on the web visit
https://groups.google.com/d/msgid/cbioportal/6892e6af14ee42bcb2973d4d0892898f%40med.uni-duesseldorf.de.
** This email originated from an EXTERNAL sender to CHOP. Proceed with caution when replying, opening attachments, or clicking links. Do not disclose your CHOP credentials, employee information, or protected health information to a potential hacker**.